Significance of IASLC/ATS/ERS classification for early-stage lung adenocarcinoma patients in predicting benefit from adjuvant chemotherapy

Antzeko izenburuak

• The New IASLC/ATS/ERS Lung Adenocarcinoma Classification: what the surgeon should know
  nork: Eguchi, Takashi, et al.
  Argitaratua: (2014)
• Implementing the new IASLC/ATS/ERS classification of lung adenocarcinomas: results from international and Chinese cohorts
  nork: Lee, Ming-Ching, et al.
  Argitaratua: (2014)
• The IASLC/ATS/ERS classification of lung adenocarcinoma-a surgical point of view
  nork: Fang, Wentao, et al.
  Argitaratua: (2014)
• Validation of the new IASLC/ATS/ERS lung adenocarcinoma classification: a surgeon’s perspective
  nork: Rocco, Raffaele, et al.
  Argitaratua: (2014)
• Pulmonary adenocarcinoma: implications of the recent advances in molecular biology, treatment and the IASLC/ATS/ERS classification
  nork: Revannasiddaiah, Swaroop, et al.
  Argitaratua: (2014)